Impact of Glucose-Insulin-Potassium on Mortality and Morbidity in Over 20,000 Patients With Acute Myocardial Infarction: The CREATE-ECLA International Trial - CREATE-ECLA - GIK

Description:

The goal of the trial was to evaluate treatment with a high-dose glucose, insulin, and potassium (GIK) infusion compared with control in patients with acute myocardial infarction (MI).